Evidence map›Paper›PMID 26559640›Full record

ArticleBMC research notes2015

Automated amplicon design suitable for analysis of DNA variants by melting techniques.

Per Olaf Ekstrøm, Sigve Nakken, Morten Johansen, Eivind Hovig

Abstract read
In one paragraph

Article in BMC research notes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Genetic variants of prospectively demonstrated phenocopies inHereditary cancer in clinical practice · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Per Olaf EkstrømDepartment of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo, 0310, Norway. pok@rr-research.no.
Sigve NakkenDepartment of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo, 0310, Norway. sigven@ifi.uio.no.
Morten JohansenDepartment of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo, 0310, Norway. morj@ifi.uio.no.
Eivind HovigDepartment of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo, 0310, Norway. ehovig@ifi.uio.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe technological development of DNA analysis has had tremendous development in recent years, and the present deep sequencing techniques present unprecedented opportunities for detailed and high-throughput DNA variant detection. Although DNA sequencing has had an exponential decrease in cost per base pair analyzed, focused and target-specific methods are however still much in use for analysis of DNA variants. With increasing capacity in the analytical procedures, an equal demand in automated amplicon and primer design has emerged.

resultsWe have constructed a web-based tool that is able to batch design DNA variant assay suitable for analysis by denaturing gel/capillary electrophoresis and high resolution melting. The tool is developed as a computational workflow that implements one of the most widely used primer design tools, followed by validation of primer specificity, as well as calculation and visualization of the melting properties of the resulting amplicon, with or without an artificial high melting domain attached. The tool will be useful for scientists applying DNA melting techniques in analysis of DNA variations. The tool is freely available at http://meltprimer.ous-research.no/ .

conclusionHerein, we demonstrate a novel tool with respect to covering the whole amplicon design workflow necessary for groups that use melting equilibrium techniques to separate DNA variants.

Indexed as

Nucleic Acid DenaturationAutomation, LaboratoryDNADNA Mutational AnalysisElectrophoresis, CapillaryHumansInternetMutationPolymerase Chain ReactionReproducibility of ResultsUser-Computer InterfaceDNA

Identifiers

PMID26559640
PMCPMC4642734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.